Codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution — RxCUI 991486
RxNorm drug concept · Semantic clinical drug
RxCUI 991486
Semantic clinical drug · SCD
● Current RxNorm concept 5 FDA products
7 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI991486
Official nameCodeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascodeine phosphate 10 MG / promethazine HCl 6.25 MG per 5 ML Oral Syrup; codeine phosphate 10 MG / promethazine HCl 6.25 MG in 5 mL Oral Solution
FDA products mapped5
Package NDCs mapped7
Reported Medicaid activity (SDUD)21,535 prescriptions · 33 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Codeine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Codeine Sulfate tablets are used to treat mild to moderate pain when other pain relievers — like ibuprofen or acetaminophen — haven't worked well enough. It's an opioid, so it's on...
- This is really important: do not drink alcohol while taking codeine — the combination can dangerously slow or stop your breathing. The same goes for sleep aids, anxiety medications...
- Can I take codeine with my other medications or have a drink?
- The most common things people notice are drowsiness, dizziness, nausea, constipation, and sweating — those are expected and usually manageable. What you need to watch out for are s...
🕸️ Concept Web — How Codeine phosphate 2 MG/ML / promethazine hydroch... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution
RxCUI 991486 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 5
The active substance itself — no strength, form, or brand attached yet.
-
Codeine
2670IN -
Promethazine
8745IN -
Codeine / promethazine
214444MIN -
Codeine phosphate
2672PIN -
Promethazine hydrochloride
142445PIN
-
Codeine
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Codeine / promethazine Oral Solution
375719SCDF -
Codeine phosphate / promethazine hydrochloride Oral Solution
2647291SCDFP -
Codeine / promethazine Oral Liquid Product
1155151SCDG -
Codeine / promethazine Oral Product
1155152SCDG -
Codeine phosphate / promethazine hydrochloride Oral Liquid Product
2660055SCDGP -
Codeine phosphate / promethazine hydrochloride Oral Product
2661038SCDGP -
Oral Solution
316968DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Codeine / promethazine Oral Solution
-
Clinical & branded drugs 2
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Codeine phosphate 2 MG/ML
832866SCDC -
Promethazine hydrochloride 1.25 MG/ML
991457SCDC
-
Codeine phosphate 2 MG/ML
Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Codeine phosphate 2 MG/ML
SCDC · 832866 -
Promethazine hydrochloride 1.25 MG/ML
SCDC · 991457 -
Codeine / promethazine Oral Solution
SCDF · 375719 -
Codeine phosphate / promethazine hydrochloride Oral Solution
SCDFP · 2647291 -
Codeine / promethazine Oral Liquid Product
SCDG · 1155151 -
Codeine / promethazine Oral Product
SCDG · 1155152 -
Codeine phosphate / promethazine hydrochloride Oral Liquid Product
SCDGP · 2660055 -
Codeine phosphate / promethazine hydrochloride Oral Product
SCDGP · 2661038
📦 FDA Products & Package NDCs
5 products · 7 package NDCs
7 package NDCs map to RxCUI 991486 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00713-0823-75 | 473 mL in 1 BOTTLE, PLASTIC (0713-0823-75) | Promethazine Hydrochloride and Codeine Phosphate | Cosette Pharmaceuticals, Inc. | 2025-12-19 |
| 17856-0065-01 | 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0065-1) / 5 mL... | Promethazine Hydrochloride and Codeine Phosphate | ATLANTIC BIOLOGICALS CORP. | 2020-08-07 |
| 17856-0065-02 | 1 CUP, UNIT-DOSE in 1 BAG (17856-0065-2) / 5 mL in 1 CUP, U... | Promethazine Hydrochloride and Codeine Phosphate | ATLANTIC BIOLOGICALS CORP. | 2025-06-04 |
| 27808-0065-02 | 473 mL in 1 BOTTLE, PLASTIC (27808-065-02) | Promethazine Hydrochloride and Codeine Phosphate | Cranbury Pharmaceuticals, LLC | 2018-03-12 |
| 70752-0139-06 | 118 mL in 1 BOTTLE, PLASTIC (70752-139-06) | Promethazine Hydrochloride and Codeine Phosphate | QUAGEN PHARMACEUTICALS LLC | 2020-10-08 |
| 70752-0139-12 | 473 mL in 1 BOTTLE, PLASTIC (70752-139-12) | Promethazine Hydrochloride and Codeine Phosphate | QUAGEN PHARMACEUTICALS LLC | 2020-10-08 |
| 72162-2042-02 | 473 mL in 1 BOTTLE, PLASTIC (72162-2042-2) | Promethazine Hydrochloride and Codeine Phosphate | Bryant Ranch Prepack | 2018-03-12 |
Observed labelers:
ATLANTIC BIOLOGICALS CORP. (2) ·
QUAGEN PHARMACEUTICALS LLC (2) ·
Bryant Ranch Prepack (1) ·
Cosette Pharmaceuticals, Inc. (1) ·
Cranbury Pharmaceuticals, LLC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.0643
Range $0.0643–$0.0643
· middle 50% $0.0643–$0.0643
· 3 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.